Further analysis of the specific cancer types revealed higher BRPF1 expression in lymphoma, while lower expression levels were observed in hepatobiliary, pancreatic, and prostate cancers (Fig. 5B). This evidence concerns the gene BRPF1 and Familial prostate cancer.